Myasthenia gravis represents chronic autoimmune disease that primarily targets the neuromuscular junction. This junction facilitates the transfer of signals from nerves to muscles, enabling movement. In myasthenia gravis, the body's immune system incorrectly attacks these receptors, causing weakness and fatigue in the motor units. The indications